Neuroendocrinology News

A team of researchers identified brain patterns that appear to underlie healthy emotional and behavioral responses to stress.

A targeted screening program to detect acromegaly in at-risk patients is feasible and could reduce disease complications and health care costs, according to a retrospective literature review.

Adolescent offspring of mothers with preeclampsia have increased hypothalamic–pituitary–adrenal axis activity that results in mild hypercortisolism, according to study findings published in Clinical Endocrinology.

Recommended European Commission regulatory criteria regarding endocrine-disrupting chemicals do not go far enough to protect human health, according to a statement released by the Endocrine Society.

The FDA approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for PET scan imaging, according to an agency press release.

ORLANDO, Fla. — Patients with neuroendocrine tumors are more likely to have increased B-lymphocyte stimulator levels compared with healthy controls, and these elevated levels may be associated with more severe disease during follow-up.

BOSTON — In this video exclusive, Tamara Wexler, MD, PhD, director of the Pituitary Center at New York University Langone Medical Center, gives her perspective on current research into traumatic brain injury.

BOSTON — Laurence Katznelson, MD, an Endocrine Today Editorial Board member and endocrinologist from Stanford University, gives his perspective on a number of presentations and posters involving pituitary diseases.

BOSTON — A high prevalence of pituitary hormone deficiencies has been found among Veterans who sustain mild traumatic brain injury, according to data presented here.

In families affected by multiple endocrine neoplasia type 1, the lag time between diagnosis of the index case and diagnosis of other family members may lead to negative outcomes, including death, for the non-index cases, according to recent findings.